DK0727986T3 - Behandling af migræne - Google Patents

Behandling af migræne

Info

Publication number
DK0727986T3
DK0727986T3 DK93907357T DK93907357T DK0727986T3 DK 0727986 T3 DK0727986 T3 DK 0727986T3 DK 93907357 T DK93907357 T DK 93907357T DK 93907357 T DK93907357 T DK 93907357T DK 0727986 T3 DK0727986 T3 DK 0727986T3
Authority
DK
Denmark
Prior art keywords
blocking agent
migraines
treatment
administered
relates
Prior art date
Application number
DK93907357T
Other languages
Danish (da)
English (en)
Inventor
Arthur M Goldberg
Leonard Lachman
Original Assignee
Ribogene Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ribogene Inc filed Critical Ribogene Inc
Application granted granted Critical
Publication of DK0727986T3 publication Critical patent/DK0727986T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Pain & Pain Management (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Non-Silver Salt Photosensitive Materials And Non-Silver Salt Photography (AREA)
  • Electrical Discharge Machining, Electrochemical Machining, And Combined Machining (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Disintegrating Or Milling (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Catalysts (AREA)
DK93907357T 1992-03-13 1993-03-08 Behandling af migræne DK0727986T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US07/850,566 US5242949A (en) 1992-03-13 1992-03-13 Treating classic migraine
PCT/US1993/002132 WO1993017672A1 (en) 1992-03-13 1993-03-08 Treatment of migraine

Publications (1)

Publication Number Publication Date
DK0727986T3 true DK0727986T3 (da) 2000-10-30

Family

ID=25308498

Family Applications (1)

Application Number Title Priority Date Filing Date
DK93907357T DK0727986T3 (da) 1992-03-13 1993-03-08 Behandling af migræne

Country Status (18)

Country Link
US (1) US5242949A (de)
EP (1) EP0727986B1 (de)
JP (1) JP2839207B2 (de)
KR (1) KR950701215A (de)
AT (1) ATE193441T1 (de)
AU (1) AU675931B2 (de)
CA (1) CA2131991C (de)
DE (1) DE69328792T2 (de)
DK (1) DK0727986T3 (de)
ES (1) ES2148222T3 (de)
FI (1) FI944236A (de)
GR (1) GR3034188T3 (de)
HU (1) HUT71834A (de)
MX (1) MX9301393A (de)
NO (1) NO943372L (de)
PH (1) PH30101A (de)
PT (1) PT727986E (de)
WO (1) WO1993017672A1 (de)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5408026A (en) * 1993-08-23 1995-04-18 Cowan; Patrick J. Curable and cured organosilicon compositions, and process for making same
US5891885A (en) * 1996-10-09 1999-04-06 Algos Pharmaceutical Corporation Method for treating migraine
US6685951B2 (en) 2001-07-05 2004-02-03 R. T. Alamo Ventures I, Inc. Administration of dihydroergotamine as a sublingual spray or aerosol for the treatment of migraine
US20030198669A1 (en) * 2001-07-05 2003-10-23 R.T. Alamo Ventures I, Llc Compositions and methods for rapid dissolving formulations of dihydroergotamine and caffeine for the treatment of migraine
US20030017175A1 (en) * 2001-07-05 2003-01-23 R.T. Alamo Ventures I, Inc. Sublingual administration of dihydroergotamine for the treatment of migraine
US7022342B2 (en) 2002-03-28 2006-04-04 Andrx Corporation, Inc. Controlled release oral dosage form of beta-adrenergic blocking agents
EP2425820B1 (de) 2007-02-11 2015-04-08 MAP Pharmaceuticals Inc Verfahren zur therapeutischen Verabreichung von DHE zur schnellen Linderung von Migräne bei gleichzeitiger Minimierung von Nebenwirkungsprofilen
WO2008115797A1 (en) * 2007-03-16 2008-09-25 Pavo, Inc. Therapeutic compositions and methods
WO2009103150A1 (en) * 2008-02-20 2009-08-27 Kevin David Smith Method for treating migraine headaches
AU2012287120B2 (en) 2011-07-22 2017-02-23 The University Of Chicago Treatments for migraine and related disorders
AU2013361337A1 (en) 2012-12-21 2015-07-09 Map Pharmaceuticals, Inc. 8'-Hydroxy-Dihydroergotamine compounds and compositions

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4394390A (en) * 1979-08-03 1983-07-19 University Of Kentucky Research Foundation Nasal dosage forms of propranol
US4284648A (en) * 1979-08-03 1981-08-18 The University Of Kentucky Research Foundation Nasal administration of propranolol
US4428883A (en) * 1981-03-06 1984-01-31 The University Of Kentucky Research Foundation Novel method of administering β-blockers and novel dosage forms containing same

Also Published As

Publication number Publication date
EP0727986A4 (de) 1995-04-25
EP0727986A1 (de) 1996-08-28
ATE193441T1 (de) 2000-06-15
CA2131991A1 (en) 1993-09-16
AU675931B2 (en) 1997-02-27
US5242949A (en) 1993-09-07
FI944236A0 (fi) 1994-09-13
PT727986E (pt) 2000-11-30
KR950701215A (ko) 1995-03-23
JPH08500329A (ja) 1996-01-16
PH30101A (en) 1996-12-27
AU3799193A (en) 1993-10-05
FI944236A (fi) 1994-11-11
EP0727986B1 (de) 2000-05-31
JP2839207B2 (ja) 1998-12-16
GR3034188T3 (en) 2000-11-30
MX9301393A (es) 1994-08-31
NO943372L (no) 1994-11-14
NO943372D0 (no) 1994-09-12
HU9402612D0 (en) 1994-11-28
DE69328792T2 (de) 2001-02-01
HUT71834A (en) 1996-02-28
WO1993017672A1 (en) 1993-09-16
CA2131991C (en) 1999-07-06
ES2148222T3 (es) 2000-10-16
DE69328792D1 (de) 2000-07-06

Similar Documents

Publication Publication Date Title
TW200607512A (en) Use of optically pure (S,S)-reboxetine in the manufacture of a medicament for the treatment or prevention of migraine headaches
DK0727986T3 (da) Behandling af migræne
NZ285159A (en) Treatment of benign prostatic hyperplasia, endometriosis, prostatic carcinoma and obesity by administration of droloxifene
DK71387D0 (da) Terapeutisk middel til behandling af psoriasis
SE9601395D0 (sv) New therapeutic treatment 1
HUP0002836A2 (hu) Makrociklusos bisz(3,3'-indolil)-maleinimid-származékok alkalmazása bőrrendellenességek kezelésére szolgáló gyógyszerkészítmények előállítására
EA199800864A1 (ru) Способ лечения при боли, вызванной мигренью
DE69924979D1 (de) Behandlung von chronischen schmerzen
NO962221L (no) Anvendelse av dimeticon for behandling av konstipasjon
DK0984787T3 (da) Anvendelse af lavmolekylære hepariner til forebyggelse og behandling af hjerneødemer
EA200001058A1 (ru) Новые способы лечения нервных расстройств
NO20013717D0 (no) Fremgangsmåte for behandling av hodepine
NO984196D0 (no) Fremgangsmåte for behandling av stoffmisbruk
NO984198L (no) FremgangsmÕte for behandling av aggresjon
NO984190L (no) FremgangsmÕte for behandling av insomnia
DK1304107T3 (da) Anvendelse af oxozolidinonderivater til behandling af psoriasis
UA50329A (uk) Спосіб лікування первинної бешихи
UA31156A (uk) Спосіб лікування пневмоентеритів телят
UA33498A (uk) Спосіб лікування терапевтично резистентних форм шизофренії
UA10257A (uk) Спосіб фізіотерапевтичного впливу на організм людини